|  | Study period | ||||||
---|---|---|---|---|---|---|---|---|
Time pointsa | Â | Â | ||||||
Enrollment | Allocation/intervention | Post intervention | Follow up | Close out | ||||
Preoprative visit | Before anesthesia | During surgery | Day 1 | Day 2 | Day 3 | Day X | Hospital discharge | |
(D-1 or D-2 before surgery) | ||||||||
Enrollment | ||||||||
 Eligibility screen | X |  |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |  |
 Physical examinationb | X |  |  |  |  |  |  |  |
 History of previous diseasec | X |  |  |  |  |  |  |  |
 FEV (1) and FVC | X |  |  |  |  |  |  |  |
 Euroscore 2 | X |  |  |  |  |  |  |  |
 Creatininemia (μmol/L) | X |  |  |  |  |  |  |  |
 Randomization |  | x |  |  |  |  |  |  |
Intervention | ||||||||
 Type of procedure |  |  | x |  |  |  |  |  |
 CPB (in minutes) |  |  | x |  |  |  |  |  |
 Number of red blood cell transfusions |  |  | x |  |  |  |  |  |
 Number of and reasons for manual insufflation |  |  | x |  |  |  |  |  |
Assessments | ||||||||
 Temperature |  |  |  | x | x | x |  |  |
 PaO2 |  |  |  | x | x | x |  |  |
 FiO2 |  |  |  | x | x | x |  |  |
 Ventilation mode |  |  |  | x | x | x |  |  |
 Hemoglobinemia |  |  |  | x | x | x |  |  |
 Leucocytemia |  |  |  | x | x | x |  |  |
 Quantity of bleeding |  |  |  | x | x | x |  |  |
 Collection of data on the occurrence of primaryd and secondarye endpoints |  |  |  | x | x | x | x | x |
 Serious adverse events |  |  |  | x | x | x | x | x |